Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - AUXILIUM PHARMACEUTICALS INC | a13-14691_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 11, 2013
Auxilium Pharmaceuticals, Inc.
(Exact Name of Registrant Specified in Charter)
|
Delaware (State or Other Jurisdiction of Incorporation) |
|
000-50855 (Commission File Number) |
|
23-3016883 (I.R.S. Employer Identification No.) |
|
640 Lee Road |
|
|
|
Chesterbrook, PA |
|
19087 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (484) 321-5900
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On June 11, 2013, Auxilium Pharmaceuticals, Inc. (“Auxilium”) and Men’s Health Network (“MHN”) issued a joint press release announcing the launch of a new health awareness program called “Ask About the Curve” to provide information about Peyronie’s disease (“PD”) and to help empower men to have meaningful discussions about their condition with their partner and their healthcare provider.
The foregoing is qualified in its entirety by the text of the press release attached as Exhibit 99.1 hereto and incorporated herein by reference. All readers are encouraged to read the entire text of the joint press release attached hereto.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
99.1 |
|
Press Release, dated June 11, 2013, jointly issued by Auxilium Pharmaceuticals, Inc. and Men’s Health Network. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
AUXILIUM PHARMACEUTICALS, INC. | |
|
|
|
|
|
|
|
|
|
Date: June 11, 2013 |
By: |
/s/ Andrew I. Koven |
|
|
|
|
|
|
|
Andrew I. Koven |
|
|
|
Chief Administrative Officer and General Counsel |